Strive to develop female non-hormonal contraceptives that reduce the risks of gynecological pathologies and breast cancer.

Development of female non-hormonal contraceptives (NHCs) is a laudable goal because hormonal (steroidal) contraceptives are either contraindicated or not well tolerated by a substantial proportion of women. Whereas currently available hormonal contra…

Preview only. Read the full abstract at the source